Yahoo

European Growth Stocks Insiders Are Betting On In January 2026

As Europe navigates renewed trade tensions and geopolitical uncertainties, the pan-European STOXX Europe 600 Index has seen a decline, reflecting broader market challenges. Despite this backdrop, business activity in the eurozone remains positive with heightened optimism in the business outlook, offering potential opportunities for growth-focused investors.In such an environment, companies with strong insider ownership can be particularly appealing as they often indicate confidence from those who know the company best.

Top 10 Growth Companies With High Insider Ownership In Europe

Name

Insider Ownership

Earnings Growth

Warimpex Finanz- und Beteiligungs (WBAG:WXF)

25.9%

100.6%

S.M.A.I.O (ENXTPA:ALSMA)

16.1%

76.1%

MilDef Group (OM:MILDEF)

13.7%

86.4%

KebNi (OM:KEBNI B)

35%

73%

Hanza (OM:HANZA)

24.4%

49.2%

CTT Systems (OM:CTT)

17.5%

52%

Clavister Holding AB (publ.) (OM:CLAV)

18%

113.2%

Circus (XTRA:CA1)

21.9%

77%

CD Projekt (WSE:CDR)

29.7%

48.7%

Bonesupport Holding (OM:BONEX)

10.3%

58.0%

Click here to see the full list of 224 stocks from our Fast Growing European Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

EnergyVision

Simply Wall St Growth Rating:★★★★☆☆

Overview:EnergyVision NV is a Belgian company offering solar energy and mobility-as-a-service solutions to corporate and residential clients, with a market cap of €626.11 million.

Operations:The company generates revenue from several segments, including EPC Activity (€66.65 million), Asset-Based Energy (€18.88 million), Asset-Based Mobility (€6.11 million), and Non-Asset-Based Energy (€34.29 million).

Insider Ownership:10.1%

EnergyVision, a European growth company, is trading below analyst price targets with expectations of a 30.8% increase. Despite high debt levels, its earnings grew by 56.8% last year and are forecast to grow at 43.2% annually, outpacing the Belgian market's 14.7%. While revenue growth is slower than some peers at 17.7%, it still surpasses the local market average of 7.7%. Insiders have not engaged in significant trading activity recently.

ENXTBR:ENRGY Ownership Breakdown as at Jan 2026
ENXTBR:ENRGY Ownership Breakdown as at Jan 2026

Altri SGPS

Simply Wall St Growth Rating:★★★★☆☆

Overview:Altri SGPS is a company that produces and sells cellulosic fibers both in Portugal and internationally, with a market cap of €912.84 million.

Operations:The company's revenue primarily comes from the production and commercialization of cellulosic fibers, amounting to €692 million.

Insider Ownership:12.4%

Altri SGPS is forecasted to experience significant annual earnings growth of 33.9%, outpacing the Portuguese market's 13.6%. Despite this, recent financial results show a decline, with a third-quarter net loss of €1.66 million compared to a net income of €27.6 million last year, and sales dropping to €162.14 million from €203.51 million year-over-year. Analysts agree on a potential stock price increase of 23.1%, but dividends are not well covered by earnings or cash flows.

ENXTLS:ALTR Earnings and Revenue Growth as at Jan 2026
ENXTLS:ALTR Earnings and Revenue Growth as at Jan 2026

AlzChem Group

Simply Wall St Growth Rating:★★★★☆☆

Overview:AlzChem Group AG, with a market cap of €1.60 billion, develops, produces, and markets a range of chemical specialties across Germany, the European Union, the rest of Europe, Asia, the NAFTA region, and internationally.

Operations:The company's revenue is primarily derived from its Specialty Chemicals segment, which contributes €370.59 million, and its Basics & Intermediates segment, accounting for €163.48 million.

Insider Ownership:15.5%

AlzChem Group, a specialty chemicals firm, is poised for growth with a €120 million investment in expanding its production facilities to enhance its market presence in sports, food, and health sectors. Despite volatile share prices recently, the company reported robust earnings growth of 23.4% over the past year and expects revenue to grow at 11.8% annually, outpacing the German market. Trading below estimated fair value by 31.5%, AlzChem maintains high insider ownership without recent substantial insider trading activity.

XTRA:ACT Earnings and Revenue Growth as at Jan 2026
XTRA:ACT Earnings and Revenue Growth as at Jan 2026

Where To Now?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTBR:ENRGY ENXTLS:ALTR and XTRA:ACT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: